Psychosocial Impact of Von Hippel-Lindau Disease: Levels and Sources of Distress
Overview
Authors
Affiliations
Von Hippel-Lindau disease (VHL) is a hereditary tumor susceptibility syndrome, characterized by an increased risk of developing multiple benign and malignant tumors at various sites and ages with limited preventive options. This study evaluates the prevalence of distress among VHL family members and factors associated significantly with such distress. Forty-eight families with a VHL mutation were identified via the nine family cancer clinics in the Netherlands. In total, 171 family members (carriers, 50% at-risk, non-carriers) were approached, of whom 123 (72%) completed a self-report questionnaire. Approximately 40% of the VHL family members reported clinically relevant levels of distress, approaching 50% among the carriers and, possibly even more striking, 36% among the non-carriers. Having lost a first degree relative due to VHL during adolescence (OR 11.2; 95% CI 1.4-86.9) was related significantly to heightened levels of distress. Approximately, only one-third of those who reported heightened levels of distress had received professional psychosocial support. A substantial percentage of family members experience clinically relevant levels of distress. We would recommend the introduction of a procedure for screening for distress in this vulnerable population. Special attention should be paid to those individuals who have lost a close relative due to VHL during adolescence.
Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant.
Onnekink A, Klatte D, van Hooft J, van den Berg S, van der Zwaan S, van Doorn R Mol Genet Genomic Med. 2025; 13(2):e70045.
PMID: 39936490 PMC: 11815477. DOI: 10.1002/mgg3.70045.
A Von Hippel-Lindau Syndrome Case Diagnosed While Hospitalized for Major Depression.
Alptekin F Psychiatry Clin Psychopharmacol. 2024; 34(2):197-200.
PMID: 39165895 PMC: 11332558. DOI: 10.5152/pcp.2024.23765.
Kaffai S, Angelova-Toshkin D, Weins A, Ickinger S, Steinke-Lange V, Vollert K Front Pediatr. 2024; 12:1410061.
PMID: 38887560 PMC: 11180882. DOI: 10.3389/fped.2024.1410061.
Disclosure of genetic risk to dating partners among young adults with von Hippel-Lindau disease.
Bond E, Yashar B, Else T, Osborne J, Marvin M Fam Cancer. 2022; 22(2):203-215.
PMID: 35984582 DOI: 10.1007/s10689-022-00311-2.
Multidisciplinary integrated care pathway for von Hippel-Lindau disease.
Wolters W, Dreijerink K, Giles R, van der Horst-Schrivers A, van Nesselrooij B, Zandee W Cancer. 2022; 128(15):2871-2879.
PMID: 35579632 PMC: 9542729. DOI: 10.1002/cncr.34265.